Long-term virological outcome in children on antiretroviral therapy in the UK and Ireland-Reference-Cited by-同舟云学术

Long-term virological outcome in children on antiretroviral therapy in the UK and Ireland

Published:2014-10-23 Issue:16 Volume:28 Page:2395-2405
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Duong Trinh,Judd Ali,Collins Intira Jeannie,Doerholt Katja,Lyall Hermione,Foster Caroline,Butler Karina,Tookey Pat,Shingadia Delane,Menson Esse,Dunn David T.,Gibb Di M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference38 articles.

1. HIV-1-resistance-associated mutations after failure of first-line antiretroviral treatment among children in resource-poor regions: a systematic review.;Sigaloff;Lancet Infect Dis,2011

2. Risk of triple-class virological failure in children with HIV: a retrospective cohort study.;Castro;Lancet,2011

3. Antiretroviral treatment for children with peripartum nevirapine exposure.;Palumbo;N Engl J Med,2010

4. Nevirapine versus ritonavir-boosted lopinavir for HIV-infected children.;Violari;N Engl J Med,2012

5. Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.;Lancet,2013

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and predictors of virological failure among HIV infected children and adolescents on first-line antiretroviral therapy in East Shewa hospitals, Oromia Region, Ethiopia: A retrospective follow up study;PLOS ONE;2023-11-30

2. Determinants of nonsuppression of HIV viral load among children receiving antiretroviral therapy in the Simiyu region: a cross-sectional study;AIDS Research and Therapy;2023-04-13

3. Prevalence and predictors of virological failure in pediatric patients on HAART in sub-Saharan Africa: a systematic review and meta-analysis;Pan African Medical Journal;2023

4. Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial;The Lancet HIV;2022-09

5. Long-term outcomes of early initiated antiretroviral therapy in sub-Saharan children: a Cameroonian cohort study (ANRS-12140 Pediacam study, 2008–2013, Cameroon);BMC Pediatrics;2021-04-21